Deep-Learning-Driven Quantification of Interstitial Fibrosis in Digitized Kidney Biopsies.

Journal: The American journal of pathology
PMID:

Abstract

Interstitial fibrosis and tubular atrophy (IFTA) on a renal biopsy are strong indicators of disease chronicity and prognosis. Techniques that are typically used for IFTA grading remain manual, leading to variability among pathologists. Accurate IFTA estimation using computational techniques can reduce this variability and provide quantitative assessment. Using trichrome-stained whole-slide images (WSIs) processed from human renal biopsies, we developed a deep-learning framework that captured finer pathologic structures at high resolution and overall context at the WSI level to predict IFTA grade. WSIs (n = 67) were obtained from The Ohio State University Wexner Medical Center. Five nephropathologists independently reviewed them and provided fibrosis scores that were converted to IFTA grades: ≤10% (none or minimal), 11% to 25% (mild), 26% to 50% (moderate), and >50% (severe). The model was developed by associating the WSIs with the IFTA grade determined by majority voting (reference estimate). Model performance was evaluated on WSIs (n = 28) obtained from the Kidney Precision Medicine Project. There was good agreement on the IFTA grading between the pathologists and the reference estimate (κ = 0.622 ± 0.071). The accuracy of the deep-learning model was 71.8% ± 5.3% on The Ohio State University Wexner Medical Center and 65.0% ± 4.2% on Kidney Precision Medicine Project data sets. Our approach to analyzing microscopic- and WSI-level changes in renal biopsies attempts to mimic the pathologist and provides a regional and contextual estimation of IFTA. Such methods can assist clinicopathologic diagnosis.

Authors

  • Yi Zheng
    Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, 300211 Tianjin, China.
  • Clarissa A Cassol
    Department of Pathology, Ohio State University, Columbus, Ohio, USA.
  • Saemi Jung
    Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Divya Veerapaneni
    Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Vipul C Chitalia
    Section of Nephrology, Boston University School of Medicine & Boston Medical Center, Boston, Massachusetts.
  • Kevin Y M Ren
    Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
  • Shubha S Bellur
    Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada; Medical Renal and Genitourinary Pathology, William Osler Health System, Brampton, Ontario, Canada.
  • Peter Boor
    Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Laura M Barisoni
    Department of Pathology and Medicine, Duke University, Durham, North Carolina.
  • Sushrut S Waikar
    Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and.
  • Margrit Betke
    Department of Computer Science, College of Arts and Sciences, Boston University, Boston, Massachusetts; Faculty of Computing and Data Sciences, Boston University, Boston, Massachusetts.
  • Vijaya B Kolachalama
    1Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118 USA.